Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, and Autolomous, a cloud-based, ...

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

The approval was based on results from the TROPION-Breast01 Phase III trial.

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Offers first-opening indication, oxygen and light protection, and can include an RFID chip for drug traceability and inventory management.

Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach. Contract Pharma is the premier media outlet ...